Open original FDA record ↗Recall record
- FDA identifier
- Z-0215-2009
- Company in FDA record
- Greiner Bio-One North America, Inc.
- FDA classification date
- Nov 7, 2008
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Labeling Error: Incorrect tube label reads "Z Serum Clot Activator" instead of "LH Lithium Heparin" tube. All other information on the tube label including color coding of tube was correct. Case and rack label information showed the correct information with 2 ml Lithium Heparin.
Source facts
- Action
- Consignees were notified by letter on 07/29/2008. Notification letters to distributors instructed them to stop distribution of the product and destroy all affected lots of the product. In addition, notification letters addressed to users instructed them to destroy and discard all products from the item and affected lots. The "Product Disposition Form" must be completed by the consignee and returned to Greiner Bio-One North America, Inc. For questions or additional information, contact Greiner Bio-One North America, Inc. at 704-261-7800.
- Initiated
- 2008-07-29
- Root cause
- Labeling mix-ups
- Terminated
- 2009-08-26
- Distribution
- Worldwide including USA (states of AK, AL, AR, CA, CO, DE, GA, ID, IL, IN, KS, LA, MA, MI, MO, MS, NC, ND, NE, NH, NY, OH, OK, OR, PA, RI, SC, SD, TX, VA, VT, WA, and WI) and country of Canada.
- Recall number
- Z-0215-2009
- Recall status
- Terminated
- CDRH record ID
- 73219
- FDA classified
- 2008-11-07
- Recall event number
- 49371